Product Specifications Product Name: GLP-1-S Compound: GLP-1 Grade: Research Use Only Form: Lyophilized peptide Purity: 99% (HPLC verified) Testing: Third-party laboratory tested Quality & Testing Standards Each batch of GLP-1-S undergoes independent third-party laboratory analysis to confirm peptide purity, molecular integrity, and absence of contaminants
Diabetes Care (2020) 43(6):13525
Common causes include water retention (especially after dose increases or during hormonal fluctuations), muscle gain offsetting fat loss (particularly in people who are exercising consistently), metabolic adaptation, and changes in dietary habits that may have gradually increased caloric intake
Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine
GLP-1 medications mimic this hormone, leading to: Delayed gastric emptying (you feel full longer)
Common to AD and PD, pathological vascular disorders and changes in the interaction between blood vessels and the elements of the nervous system within the neurovascular unit indicate the importance of restoring normal metabolic interactions between neurons, glia, and vascular cells
